57 results
8-K
EX-2.1
CATX
Perspective Therapeutics Inc
12 Dec 23
Entry into a Material Definitive Agreement
8:05am
” means any loss, damage, injury, liability, claim, settlement, judgment, award, fine, penalty, Tax, fee, charge, cost or expense of any nature (including … injury, or property damage.
(b) Except as set forth on Section 4.13(b) of the Disclosure Schedule, since January 1, 2021, there has been no action
8-K
EX-99.1
CATX
Perspective Therapeutics Inc
28 Nov 23
Perspective Therapeutics Announces Publication of Four Preclinical Studies in Peer-Reviewed Journals
4:11pm
of the potential for subclinical acute kidney injury (AKI) arising from radionuclide therapies and have the potential to guide more effective therapies … of kidney injury in response to radioligand therapies and has the potential to assist in optimizing therapies.
Identification and feasibility of the use
424B5
CATX
Perspective Therapeutics Inc
13 Jul 23
Prospectus supplement for primary offering
4:41pm
of our devices, as well as product malfunctions that are likely to cause or contribute to death or serious injury if the malfunction were to recur … in a situation where our product results in, or is alleged to result in, a personal injury to a patient, health care provider, or other user.
Viewpoint
10-KT
eo6v afxhe
1 May 23
Annual report (with FYE transition)
5:03pm
DEFM14A
ek9c11d5fblr 4wa2x
7 Nov 22
Proxy related to merger
5:20pm
PREM14A
ghag4zik7pnip23eu
25 Oct 22
Preliminary proxy related to merger
4:29pm
424B5
323yr1h
21 Oct 22
Prospectus supplement for primary offering
4:56pm
DEFA14A
EX-2.1
yk5cuo 85gt
28 Sep 22
Additional proxy soliciting materials
4:08pm
8-K
EX-2.1
uyt uf0tch
28 Sep 22
Entry into a Material Definitive Agreement
4:07pm
424B5
2ztbgcq28 0cplo
1 Oct 21
Prospectus supplement for primary offering
4:23pm
424B5
0znmie
29 Sep 20
Prospectus supplement for primary offering
4:36pm
424B5
eaqw64cju01zyh4bim0
30 Sep 19
Prospectus supplement for primary offering
10:44pm